Floatz logo

Vorinostat

AIDS-Related Plasmablastic Lymphoma

National Cancer Institute (NCI)Small moleculePhase 1/2Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
36/ 100
Competitive Position
95/ 100

Competitive context

24 Active assets in the AIDS-Related Plasmablastic Lymphoma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
National Cancer Institute (NCI)
Phase 2BB
Inno-206
National Cancer Institute (NCI)
Phase 2BB
ETOPOSIDE
National Cancer Institute (NCI)
Phase 2BB
(+)-VINCRISTINE
National Cancer Institute (NCI)
Phase 2BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 2BB

View all 27 →

Same molecule, other indications

Vorinostat is also rated in:

Non-Small-Cell Lung CarcinomaDormant
BB
Indicative ·
71 / 100
View asset →
Hodgkins lymphomaDormant
BB
Indicative ·
68 / 100
View asset →
Recurrent Non-Hodgkin LymphomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →